메뉴 건너뛰기




Volumn 23, Issue 12, 2012, Pages 909-910

Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: Report of three cases

Author keywords

Adverse effects; Anogenital warts; HPV; Imiquimod

Indexed keywords

CORTICOSTEROID; DOXYCYCLINE; IMIQUIMOD;

EID: 84871697716     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2012.012076     Document Type: Article
Times cited : (18)

References (8)
  • 1
    • 33644933659 scopus 로고    scopus 로고
    • The epidemiology of genital human papillomavirus infection
    • Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl. 1):S1-15
    • (2006) Vaccine , vol.24 , Issue.SUPPL. 1
    • Trottier, H.1    Franco, E.L.2
  • 2
    • 0031886680 scopus 로고    scopus 로고
    • Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human papillomavirus
    • Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human papillomavirus. Arch Dermatol 1998;134:25-30
    • (1998) Arch Dermatol , vol.134 , pp. 25-30
    • Edwards, L.1    Ferenczy, A.2    Eron, L.3
  • 3
    • 85172067320 scopus 로고    scopus 로고
    • The Electronic Medicines Compendium (eMC). eMC, Aldara 5% Cream-Summary of Product Characteristics. Surrey: Datapharm Communications Limited
    • The Electronic Medicines Compendium (eMC). eMC, Aldara 5% Cream-Summary of Product Characteristics. Surrey: Datapharm Communications Limited, 2010
    • (2010)
  • 4
    • 0003054985 scopus 로고    scopus 로고
    • Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts
    • Owens ML, Bridson WE, Smith SL, et al. Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts. Prim Care Update Obstet Gynecol 1998;5:151
    • (1998) Prim Care Update Obstet Gynecol , vol.5 , pp. 151
    • Owens, M.L.1    Bridson, W.E.2    Smith, S.L.3
  • 5
    • 19044390232 scopus 로고    scopus 로고
    • Imiquimod for the treatment of genital warts: A quantitative systematic review
    • Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001;1:3
    • (2001) BMC Infect Dis , vol.1 , pp. 3
    • Moore, R.A.1    Edwards, J.E.2    Hopwood, J.3    Hicks, D.4
  • 6
    • 79960696837 scopus 로고    scopus 로고
    • Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation
    • Kumar B, Narang T. Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation. Sex Transm Infect 2011;87:432
    • (2011) Sex Transm Infect , vol.87 , pp. 432
    • Kumar, B.1    Narang, T.2
  • 7
    • 77955550043 scopus 로고    scopus 로고
    • Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp
    • Kulp J, Levy S, Fein MC, et al. Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp. Arch Dermatol Res 2010;302:539-44
    • (2010) Arch Dermatol Res , vol.302 , pp. 539-544
    • Kulp, J.1    Levy, S.2    Fein, M.C.3
  • 8
    • 84855557761 scopus 로고    scopus 로고
    • Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist imiquimod
    • Damm J, Wiegand F, Harden LM, et al. Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist imiquimod. Neuroscience 2012;201:166-83
    • (2012) Neuroscience , vol.201 , pp. 166-183
    • Damm, J.1    Wiegand, F.2    Harden, L.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.